MA53546A - Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide - Google Patents
Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamideInfo
- Publication number
- MA53546A MA53546A MA053546A MA53546A MA53546A MA 53546 A MA53546 A MA 53546A MA 053546 A MA053546 A MA 053546A MA 53546 A MA53546 A MA 53546A MA 53546 A MA53546 A MA 53546A
- Authority
- MA
- Morocco
- Prior art keywords
- sulfamide
- structured
- kinase inhibitor
- saline forms
- novel hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/04—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20185743 | 2018-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53546A true MA53546A (fr) | 2021-12-15 |
Family
ID=67982092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053546A MA53546A (fr) | 2018-09-06 | 2019-09-05 | Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11866420B2 (fr) |
| EP (1) | EP3846906A1 (fr) |
| JP (1) | JP7528060B2 (fr) |
| KR (1) | KR20210057759A (fr) |
| CN (1) | CN112805065B (fr) |
| AU (1) | AU2019334693B2 (fr) |
| CA (1) | CA3111040A1 (fr) |
| EA (1) | EA202190696A1 (fr) |
| MA (1) | MA53546A (fr) |
| MX (1) | MX2021002524A (fr) |
| MY (1) | MY203097A (fr) |
| SG (1) | SG11202102110PA (fr) |
| WO (1) | WO2020049217A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3601262T3 (fi) * | 2017-03-23 | 2023-01-13 | Prosessi sulfonamidirakenteisen kinaasi-inhibiittorin valmistamiseksi | |
| EP4114359A1 (fr) * | 2020-03-05 | 2023-01-11 | Aurigene Discovery Technologies Limited | Compositions pharmaceutiques d'un inhibiteur de kinase |
| WO2024218649A2 (fr) * | 2023-04-17 | 2024-10-24 | Aurigene Oncology Limited | Combinaison d'un inhibiteur de protéine kinase avec des agents immunomodulateurs |
| WO2024246852A2 (fr) * | 2023-06-01 | 2024-12-05 | Aurigene Oncology Limited | Méthode de traitement de maladies fibrotiques à l'aide d'un inhibiteur de protéine kinase |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA111382C2 (uk) | 2011-10-10 | 2016-04-25 | Оріон Корпорейшн | Інгібітори протеїнкінази |
| FI3601262T3 (fi) * | 2017-03-23 | 2023-01-13 | Prosessi sulfonamidirakenteisen kinaasi-inhibiittorin valmistamiseksi | |
| CN113490667B (zh) * | 2018-12-29 | 2023-10-27 | 盛世泰科生物医药技术(苏州)股份有限公司 | 作为fgfr和vegfr双重抑制剂的咪唑并吡啶衍生物 |
| CA3141424C (fr) * | 2019-06-14 | 2023-11-07 | Zhengxia CHEN | Compose cyclique fusionne en tant qu'inhibiteur double de fgfr et vegfr |
-
2019
- 2019-09-05 KR KR1020217010097A patent/KR20210057759A/ko active Pending
- 2019-09-05 MA MA053546A patent/MA53546A/fr unknown
- 2019-09-05 CN CN201980058119.5A patent/CN112805065B/zh active Active
- 2019-09-05 US US17/273,774 patent/US11866420B2/en active Active
- 2019-09-05 EA EA202190696A patent/EA202190696A1/ru unknown
- 2019-09-05 WO PCT/FI2019/050629 patent/WO2020049217A1/fr not_active Ceased
- 2019-09-05 JP JP2021512769A patent/JP7528060B2/ja active Active
- 2019-09-05 MY MYPI2021000898A patent/MY203097A/en unknown
- 2019-09-05 EP EP19769549.7A patent/EP3846906A1/fr active Pending
- 2019-09-05 CA CA3111040A patent/CA3111040A1/fr active Pending
- 2019-09-05 SG SG11202102110PA patent/SG11202102110PA/en unknown
- 2019-09-05 MX MX2021002524A patent/MX2021002524A/es unknown
- 2019-09-05 AU AU2019334693A patent/AU2019334693B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MY203097A (en) | 2024-06-09 |
| EA202190696A1 (ru) | 2021-06-16 |
| WO2020049217A1 (fr) | 2020-03-12 |
| US11866420B2 (en) | 2024-01-09 |
| US20210332028A1 (en) | 2021-10-28 |
| CN112805065B (zh) | 2024-07-05 |
| CA3111040A1 (fr) | 2020-03-12 |
| JP7528060B2 (ja) | 2024-08-05 |
| EP3846906A1 (fr) | 2021-07-14 |
| CN112805065A (zh) | 2021-05-14 |
| SG11202102110PA (en) | 2021-04-29 |
| MX2021002524A (es) | 2021-04-28 |
| JP2022501328A (ja) | 2022-01-06 |
| AU2019334693A1 (en) | 2021-05-13 |
| AU2019334693B2 (en) | 2025-04-03 |
| KR20210057759A (ko) | 2021-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53546A (fr) | Nouvelles formes salines de chlorhydrate d'un inhibiteur de kinase à structure sulfamide | |
| MA54526A (fr) | NOUVELLES FORMES POLYMORPHES D'UN INHIBITEUR DE TGFBeta | |
| MA54458A (fr) | Formes cristallines et formes salines d'un inhibiteur de kinase | |
| EP4267598A4 (fr) | Nouvelles protéines inhibitrices d'insectes | |
| MA51619A (fr) | Inhibiteurs de la protéine kinase dépendante de l'adn | |
| MA51066A (fr) | Inhibiteurs d'intégrine | |
| EP3532240A4 (fr) | Base d'outillage | |
| EP4104000A4 (fr) | Pont d'outil | |
| MA54399A (fr) | Radioimmunoconjugués et polythérapie à base d'inhibiteur de point de contrôle | |
| EP3907039A4 (fr) | Magasin d'outils d'une machine-outil | |
| EP3914608A4 (fr) | Nouvelles protéines d'inhibition des insectes | |
| EP3995553A4 (fr) | Adhésif à base d'isocyanate | |
| MA55801A (fr) | Formes solides d'un inhibiteur de glyt1 | |
| CA3243183A1 (fr) | Inhibiteurs d'oncoprotéines ras | |
| EP4000258A4 (fr) | Mise à l'échelle de coefficients à base de position | |
| EP4264309A4 (fr) | Positionnement d'empreintes digitales amélioré | |
| EP4373420A4 (fr) | Vis à os | |
| EP3885377A4 (fr) | Polymère à base d'oléfine | |
| EP3730138A4 (fr) | Médicament comprenant une combinaison de sepetaprost et d'inhibiteur de la rho-kinase | |
| EP3988172A4 (fr) | Timbre adhésif à base d'eau | |
| EP4021442A4 (fr) | Inhibiteurs conjugués de la réponse à l'endommagement de l'adn | |
| EP3980001A4 (fr) | Compositions à libération prolongée d'alpha-cétoglutarate | |
| EP3849964A4 (fr) | Formes cristallines d'un composé de quinazole et ses sels de chlorhydrate | |
| EP3897660A4 (fr) | Nouvelles formes cristallines d'un composé de nrtti | |
| EP4122923A4 (fr) | Dérivé d'oxadiazole |